Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
This underscores the necessity for individuals to prepare thorough documentation when seeking approval for the medication, ensuring they meet all specified criteria
Plaintiffs in the litigation report experiencing these specific digestive system complications: Gastroparesis (stomach paralysis): The most common injury alleged in lawsuits, this condition involves partial or complete paralysis of stomach muscles that prevents proper digestion and can persist even after discontinuing medication Ileus (intestinal blockage): Added to FDA warning labels in September 2023 after post-marketing reports, this condition stops intestinal movement and can lead to life-threatening complications including infection and tissue death Intestinal obstruction and pseudo-obstruction: Physical or functional blockages requiring emergency hospitalization and often surgical intervention to prevent bowel perforation Chronic severe symptoms: Persistent vomiting, uncontrollable nausea, dangerous dehydration requiring IV fluids, and electrolyte imbalances necessitating repeated emergency department visits The FDAs decision to update warning labels demonstrates growing concern about these complications
In two clinical trials, people with obesity who received weight-loss drug Zepbound saw a greater average reduction in sleep apnea events over the course of a year, compared to people who received a non-acting placebo
Avoid the temptation to pick or squeeze pimples, as this can lead to scarring and secondary infection
-
